Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
81.45
+0.44 (0.54%)
Feb 5, 2025, 4:00 PM EST - Market closed
Insmed Employees
Insmed had 912 employees as of December 31, 2023. The number of employees increased by 176 or 23.91% compared to the previous year.
Employees
912
Change (1Y)
176
Growth (1Y)
23.91%
Revenue / Employee
$376,050
Profits / Employee
-$947,681
Market Cap
14.57B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 912 | 176 | 23.91% |
Dec 31, 2022 | 736 | 123 | 20.07% |
Dec 31, 2021 | 613 | 92 | 17.66% |
Dec 31, 2020 | 521 | 86 | 19.77% |
Dec 31, 2019 | 435 | 62 | 16.62% |
Dec 31, 2018 | 373 | 159 | 74.30% |
Dec 31, 2017 | 214 | 53 | 32.92% |
Dec 31, 2016 | 161 | 36 | 28.80% |
Dec 31, 2015 | 125 | 36 | 40.45% |
Dec 31, 2014 | 89 | 28 | 45.90% |
Dec 31, 2013 | 61 | 20 | 48.78% |
Dec 31, 2012 | 41 | -1 | -2.38% |
Dec 31, 2011 | 42 | 2 | 5.00% |
Dec 31, 2010 | 40 | 25 | 166.67% |
Dec 31, 2009 | 15 | -82 | -84.54% |
Dec 31, 2008 | 97 | 3 | 3.19% |
Dec 31, 2007 | 94 | -63 | -40.13% |
Dec 31, 2006 | 157 | 72 | 84.71% |
Dec 31, 2005 | 85 | 30 | 54.55% |
Dec 31, 2004 | 55 | 35 | 175.00% |
Dec 31, 2003 | 20 | -3 | -13.04% |
Dec 31, 2002 | 23 | -37 | -61.67% |
Dec 31, 2001 | 60 | 20 | 50.00% |
Dec 31, 2000 | 40 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
INSM News
- 26 days ago - Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 weeks ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Insmed To Present at December 2024 Investor Conferences - PRNewsWire
- 2 months ago - Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data - Seeking Alpha
- 3 months ago - Insmed To Present at November 2024 Investor Conferences - PRNewsWire
- 3 months ago - Insmed Incorporated (INSM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update - PRNewsWire